News | April 17, 2026
Salve Group launches Parasoft foot cream to address dry and cracked feet
This combination works to break down rough patches, improve moisture retention, and enhance overall skin texture
This combination works to break down rough patches, improve moisture retention, and enhance overall skin texture
The project entails a total planned capital expenditure of approximately Rs. 500 - 520 crore
The EU approval of DAWNZERA is an important milestone that reflects our ongoing commitment to bring this innovative medicine to people in need across the globe
The launch of the study was on the occasion of the International Day of Persons with Disabilities
From material selection to cooling tower management, every small decision affects long-term equipment reliability
Furthering?U.S.-based?pharmaceutical?capacity?to?produce?critical respiratory medicines?
82,514 sq ft facility to host up to 15 biotech companies, fueling the development of next-generation medicines
Dawnzera demonstrated significant and sustained HAE attack rate reduction and long-term disease control
ART-123 is a recombinant human thrombomodulin approved in Japan in 2008
The GMP-compliant facility with automated environmental monitoring accommodates both white room and class 7 and 8 cleanroom space
Subscribe To Our Newsletter & Stay Updated
